Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Attention To COVID-19 Vaccine Ads Varies Widely Across Race & Political Party, According To Realeyes

Cost to message different audience segments with the same vaccine videos can vary up to 50%


News provided by

Realeyes

Jul 14, 2021, 08:30 ET

Share this article

Share toX

Share this article

Share toX

Vaccine Ads Capture Attention Of Democrats More than Republicans
Vaccine Ads Capture Attention Of Democrats More than Republicans

NEW YORK, July 14, 2021 /PRNewswire-PRWeb/ -- Realeyes, a pioneer and leader in video attention measurement, today released new research showing how the efficacy of public service announcements (PSAs) promoting COVID-19 vaccination varies across race and political groups in the U.S.

Using front-facing cameras and the latest attention AI to measure opt-in viewers, The Realeyes Vaccine Report revealed performance across 12 prominent videos. They were released by health agencies and advocacy groups like The Ad Council, The Creative Coalition, and the Department of Health and Human Services (HHS), as well as the pharmacy-retailer Walgreens and pharmaceutical company Pfizer. Realeyes Quality Score gave each video a rating of 0-10, determining a video's ability to capture and retain attention live in market.

Polarization, social values and institutional distrust can easily override otherwise factual health information in a public health campaign.

Post this

Vaccine Ads Capture Attention Of Democrats More than Republicans

According to the report, the PSAs scored 38% higher in attention performance among Democrats than Republicans, with average Quality Scores of 5.6 and 3.8, respectively.

The highest-scoring ads differed across political parties. For Democrats, "Should I get it," from the Ad Council, and the Morgan Freeman ad "Be there," from The Creative Coalition, scored highest. The ads, with Quality Scores of 7, contained a science-led message backed up by trust.

By contrast, the two highest-scoring ads among Republicans were "It's Time," from the HHS, and the "Worship" 30-second spot, from the Ad Council. The sentimental and religious messages of these ads, with Quality Scores of 7, may have contributed to their ability to capture and retain attention among a conservative audience.

White Viewers Most Attentive To Vaccine Videos

The vaccine ads scored a whole point higher on Quality Score when seen by White viewers versus Black and Hispanic viewers. The average Quality Scores of the PSAs were: 3.6 among Asian viewers; 3.4 among Black viewers; 3.4 among Hispanic viewers; and 4.4 among White viewers.

There is a lack of consistency in the top-scoring ads among each racial group. The only ad that appeared in the top 5 lists of Black, Asian and White viewers was the science-oriented Pfizer ad, "We Moved at the Speed of Science." However, the ad had among the lowest attention performance among Hispanic viewers. The Spanish language ad "Vacunas contra el COVID," from HHS, was among the top-scoring ads among Black viewers and among the lowest scoring among Hispanic viewers.

Influence of Creative On Cost To Message Different Demographics

The effective cost of quality media exposures, due to the efficiency of the video creatives, differs across racial groups by up to 50%; the effective cost of quality media exposures, among the average of all ads tested, differs across Democrats and Republicans by 40%.

"Polarization, social values and institutional distrust can easily override otherwise factual health information in a public health campaign," said Max Kalehoff, Vice President of Marketing, Realeyes. "The video attention data underscore just how critical it is for health advocacy campaigns to ensure video creatives are nuanced to different racial groups and political dispositions, despite how strong the facts appear on their own."

To overcome audience attention disparities, the report advises video creators to adopt more agile and DIY production techniques which are perceived to be more authentic, timely and relevant. Leaders of vaccine campaigns also should ensure demographic and racial diversity of their video creators, and who resemble the audiences they seek to persuade.

Lastly, health advocates must use available tools to pre-test the resonance of their video creatives against target audiences. Despite good intentions, carefully constructed messaging for target audiences can have counterintuitive outcomes. Additionally, in situations like the COVID-19 pandemic, sentiment changes continuously, so a message that is relevant today may not be relevant tomorrow. Frequent testing is necessary to evolve messaging accordingly.

Methodology

The Vaccine Study tested twelve video public service ads that appeared on TV and social media among six discrete groups with an average of 164 viewers per video: Democrat, Republican, Asian, Hispanic, Black, and White. Using Realeyes' PreView attention-measurement product, each ad received a Quality Score, a rating of 0-10, which measures a video's ability to perform live in market. Quality Score factors in three critical elements:

1) Capture: Ability to capture audience attention in the first seconds.
2) Retain: Ability to retain the audience throughout the ad.
3) Encode: Ability to encode the brand message into the brain through emotional engagement.

About Realeyes

Using front-facing cameras and the latest in computer vision and machine learning technologies, Realeyes measures attention and emotion of opt-in participants as they watch video content online. This empowers brands publishers and technology platforms to inform and optimize their content as well as target the right videos to the right audiences. Realeyes' technology applies facial coding to predictive, big-data analytics, driving bottom-line business outcomes for brands and publishers. Founded in 2007, Realeyes has offices in New York, London, Tokyo and Budapest. Customers include brands such as Mars Inc, Church & Dwight, Hershey's and Expedia, agencies Ipsos, MarketCast and Publicis, and media companies such as Google, WarnerMedia and Teads.

Media Contact

Realeyes Analyst Team, Realeyes, +1 (646)4894629, [email protected]

SOURCE Realeyes

Related Links

http://www.realeyesit.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.